Continuing Pharmacy Education Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

An understanding of the management of patients with critical illness is vital for the critical care pharmacist. Neurocritical Care, the latest release in the Critical Care Self-Assessment Program (CCSAP), provides evidence-based updates and best practice insights for pharmacists caring for neurological critically ill patients.

Given that neurocritical care issues are seen across all ICUs, the target audience for Neurocritical Care is not only ICU and ED pharmacists across the spectrum of care but also any pharmacist caring for acutely ill patients whose management may be complicated by these challenging scenarios.

Neurocritical Care has four modules offering a total of 20.5 available continuing pharmacy education (CPE) credits. The book was developed under the leadership of Faculty Panel Chair Aaron M. Cook, Pharm.D., BCCCP.

The first module includes chapters that provide an update on the treatment of elevated intracranial pressure, as well as autoimmune neuromuscular diseases such as Guillain-Barre syndrome. The second module focuses on the management of subarachnoid hemorrhage and drug-induced neurotoxicity. The third section includes chapters on acute ischemic stroke and the management of refractory status epilepticus. The fourth section consists of three interactive features on neurogenic fever, coma, and grading literature with a specific reference to guideline development and interpretation.

Each CCSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as a full-color electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:

• Traditional review-style chapters
• Interactive cases (a series of webpages, each introduced by a sample case-based question)
• Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

CCSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphics focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice. Included with every purchase is an e-media version you can view on an e-reader, tablet, and iOS or Android smart phone.

Publisher: ACCP, 200 pages, March 2022; ISBN-13: 978-1-952291-43-2

• Release date: March 15, 2022
• BCCCP credit expiration date: September 15, 2022
• ACPE credit expiration date: March 15, 2025
• Target Audience and Learning Objectives 
• Table of Contents 
• Sample Chapter 
• Faculty and Faculty Disclosures 

Continuing Pharmacy Education Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

An understanding of the management of patients with infectious diseases is vital for the critical care pharmacist. Infectious Diseases in the ICU, the latest release in the Critical Care Self-Assessment Program (CCSAP), provides evidence-based updates and best practice insights for pharmacists caring for patients with commonly encountered infections in the ICU.

The target audience for Infectious Diseases in the ICU is not only ICU and ED pharmacists across the spectrum of care but also any pharmacist caring for acutely ill patients whose management may be complicated by these challenging scenarios.

Infectious Diseases in the ICU has four modules offering a total of 18.0 available continuing pharmacy education (CPE) credits. The book was developed under the leadership of Faculty Panel Chair Stephanie Bass, Pharm.D., BCCCP, BCPS.

Chapters in the first module provide an update on the treatment of MDR gram-negative pathogens and resistant gram-positive pathogens. The second module focuses on the management of Clostridiodes difficile and fungal infections. The third module includes chapters on endocarditis and the management of febrile neutropenia. The fourth module consists of three interactive features on therapeutic drug monitoring, intra-abdominal infection and enterocutaneous fistulas and infections in mechanical circulatory support devices.

Each CCSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as a full-color electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:

• Traditional review-style chapters
• Interactive cases (a series of webpages, each introduced by a sample case-based question)
• Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

CCSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphics focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice. Included with every purchase is an e-media version you can view on an e-reader, tablet, and iOS or Android smart phone.

Publisher: ACCP, 200 pages, September 2022; ISBN-13: 978-1-952291-56-2

• Release date: September 15, 2022
• BCCCP credit expiration date: March 15, 2023
• ACPE credit expiration date: September 15, 2025
• Target Audience and Learning Objectives 
• Table of Contents 
• Sample Chapter 
• Faculty and Faculty Disclosures 

Continuing Pharmacy Education Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

An understanding of the management of patients with coagulopathies and hypercoagulabilities is vital for the critical care pharmacist. Coagulation and Thrombotic Disorders, the latest release in the Critical Care Self-Assessment Program (CCSAP), provides evidence-based updates and best practice insights for pharmacists caring for patients with these challenging scenarios.

The target audience for Coagulation and Thrombotic Disorders is not only ICU and ED pharmacists across the spectrum of care but also any pharmacist caring for acutely ill patients whose management may be complicated by coagulopathies or hypercoagulabilities.

Coagulation and Thrombotic Disorders has four modules offering a total of 18.0 available continuing pharmacy education (CPE) credits. The book was developed under the leadership of Faculty Panel Chair Scott T. Benken, Pharm.D., MHPE, FCCM, FCCP, BCPS AQ-Cardiology.

Chapters in the first module provide a foundation on coagulation assays and the reversal of anticoagulants, antiplatelets, and fibrinolytics. The second module focuses on two major catastrophic consequences of coagulation and thrombotic disorders covering acute GI bleeding and pulmonary embolism. Chapters in the third module explore acquired hematologic disorders in the ICU. The last module consists of two interactive features on anticoagulation management in atrial fibrillation and deep vein thrombosis treatment in patients with obesity and a webcast on antithrombotic therapy in newer cardiac devices.

Each CCSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as a full-color electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:

• Traditional review-style chapters
• Interactive cases (a series of webpages, each introduced by a sample case-based question)
• Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

CCSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphics focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice. Included with every purchase is an e-media version you can view on an e-reader, tablet, and iOS or Android smart phone.

Publisher: ACCP, 200 pages, March 2023; ISBN-13: 978-1-952291-66-1

• Release date: March 15, 2023
• BCCCP credit expiration date: September 15, 2023
• ACPE credit expiration date: March 15, 2026
• Target Audience and Learning Objectives 
• Table of Contents 
• Sample Chapter 
• Faculty and Faculty Disclosures 

Continuing Pharmacy Education Credit

The American College of Clinical Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.

Given its importance to patient outcomes, optimizing analgosedation remains among the most vital targets for critical care pharmacist intervention. Analgesic regimens in the critically ill are increasingly complex in the wake of the opioid epidemic and as the enhanced recovery paradigm continues to reshape perioperative care. Additionally, overdose rates in community settings are increasing in both frequency and severity for common prescription medications, and managing the toxicologic effects of emerging drugs of abuse continues to challenge hospital providers. Toxicology and Analgesia, the latest release in the Critical Care Self-Assessment Program (CCSAP), provides evidence-based updates and best practice insights for pharmacists caring for patients with these challenging scenarios.

The target audience for Toxicology and Analgesia is not limited to ICU and ED pharmacists across the spectrum of care, but also includes any pharmacist caring for acutely ill patients with complex needs related to pain management or acute poisoning.

Analgesia and Toxicology has four modules offering a total of 18.0 available continuing pharmacy education (CPE) credits. The book was developed under the leadership of Faculty Panel Chair Sara Jordan Hyland, Pharm.D., BCCCP.

Chapters in the first module provide current guidance related to multimodal analgosedation and managing patients with opioid use disorder in the ICU. The second module explores current management of two unique populations in critical care settings: patients undergoing surgery and patients at the end of life. Chapters in the third module provide updates in toxicology spanning prescription medication overdoses, emerging drugs of abuse, and poisonings from misuse of medications/substances intended for COVID-19 prevention or treatment. The final module comprises three interactive features including a clinical case on opioid use across the continuum of critical and post-critical care, a practice-based case exploring pharmacy services and practice models related to pain management and opioid stewardship, and a biostatistics exercise on newer research study designs and analyses.

Each CCSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as a full-color electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:

• Traditional review-style chapters
• Interactive cases (a series of webpages, each introduced by a sample case-based question)
• Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

CCSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphics focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice. Included with every purchase is an e-media version you can view on an e-reader, tablet, and iOS or Android smart phone.

Publisher: ACCP, 200 pages, September 2023; ISBN-13: 978-1-952291-83-8

• Release date: September 15, 2023
• BCCCP credit expiration date: March 15, 2024
• ACPE credit expiration date: September 15, 2026
• Target Audience and Learning Objectives 
• Table of Contents 
• Sample Chapter 
• Faculty and Faculty Disclosures 

Continuing Pharmacy Education Credit

Each CCSAP release has continuing education activities that cover the most recent published data (past 3–5 years) on a specific therapeutic area or patient-care problem. This content is provided as a full-color electronic book (interactive PDF) with high-level updates designed, as appropriate to the topic, in three formats:

• Traditional review-style chapters
• Case series (major sections of learning content bookended by a sample case and its explained answer)
• Recorded webcast (PowerPoint presentation; includes PDF of the transcribed narrative)

CCSAP chapters and features are fully referenced, with clickable hyperlinks to literature compilers such as PubMed. Other links provide ready access to clinical practice guidelines, official recommendations, and patient assessment tools. Graphics focus on pivotal studies, patient care scenarios, and take-home points that can be readily integrated into clinical practice. Included with every purchase is an e-media version you can view on an e-reader, tablet, and iOS or Android smart phone.

• Release date: September 16, 2024
• BCCCP credit expiration date: March 17, 2025
• ACPE credit expiration date: September 16, 2027